Patient stem cells help identify common problem in ALS

A recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis -- Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder, new stem cell research has shown. The researchers are now designing an initial clinical trial testing the safety of the treatment in ALS patients.

Read the whole article on Science Daily

More from Science Daily